From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement

Best practice considerations by the American Society of Transplant and Cellular Therapy: Infection prevention and management after chimeric antigen receptor T cell therapy for hematological malignancies

Last Updated: Tuesday, December 9, 2025

The Infectious Diseases Special Interest Group of the American Society of Transplantation and Cellular Therapy convened an expert panel to develop best practice recommendations for infection prevention and management in CAR T-cell therapy recipients, emphasizing the importance of early Infectious Diseases consultation during treatment planning.  

Transplantation and Cellular Therapy
Advertisement
News & Literature Highlights
Advertisement
Advertisement